NL-OMON27113招募中不适用
Vaccination of Multiple Myeloma patients with RNA electroporated mature dendritic cells expressing multiple tumor antigens.
Radboud University Nijmegen Medical Center, Dept. of HematologyUniversitair Medisch Centrum Sint Radboud, Afd. Hematologie0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age 18-70 years;
- •2. Patients with stage II and III MM;
排除标准
- •1. Progressive disease (increase in M-component of >25% in the last 3 months);
- •2. Patients on immunosuppressive drugs;
研究者
相似试验
已完成
不适用
Vaccination of Multiple Myeloma patients with RNA electroporated mature dendritic cells expressing multiple tumor antigens.Kahler disease10035227Multiple myelomaNL-OMON34526niversitair Medisch Centrum Sint Radboud12
已完成
4 期
Pneumococcal Vaccination of Multiple Myeloma Patients on Novel AgentsPneumococcal InfectionFebrile NeutropeniaPneumococcal PneumoniaMultiple MyelomaNCT03619252Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology36
已完成
1 期
Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic CellsMultiple MyelomaNCT00186316Stanford University30
已完成
不适用
Covid-19 Vaccine Responsiveness in MM and WaldenstromWaldenstrom MacroglobulinemiaImmune System DisorderCovid19Multiple MyelomaNCT04830046Massachusetts General Hospital146
进行中（未招募）
1 期
Dual Vaccine Trial in Myeloproliferative NeoplasmsMyeloproliferative NeoplasmsMedDRA version: 20.1Level: LLTClassification code 10028576Term: Myeloproliferative disorderSystem Organ Class: 100000004864MedDRA version: 20.1Level: LLTClassification code 10036061Term: Polycythemia veraSystem Organ Class: 100000004864MedDRA version: 20.1Level: LLTClassification code 10015494Term: Essential thrombocythemiaSystem Organ Class: 100000004864EUCTR2019-001434-34-DKDepartment of haematology, Zealand university hospital48